<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Toxicol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Toxicology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Toxicol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2673-3080</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1838970</article-id>
<article-id pub-id-type="doi">10.3389/ftox.2026.1838970</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Shaking culture improves physiological maintenance of primary rat kidney tissue slices</article-title>
<alt-title alt-title-type="left-running-head">Kadoguchi et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/ftox.2026.1838970">10.3389/ftox.2026.1838970</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kadoguchi</surname>
<given-names>Moeno</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal Analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing - original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Matsushita</surname>
<given-names>Kohei</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Takahashi</surname>
<given-names>Jun</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Esashika</surname>
<given-names>Katsuhiro</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Jingjing</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sugimoto</surname>
<given-names>Masahiro</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/72250"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal Analysis</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tamai</surname>
<given-names>Ikumi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Arakawa</surname>
<given-names>Hiroshi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3309153"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing - original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
</contrib>
</contrib-group>
<aff id="aff1">
<label>1</label>
<institution>Faculty of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University</institution>, <city>Kanazawa</city>, <state>Ishikawa</state>, <country country="JP">Japan</country>
</aff>
<aff id="aff2">
<label>2</label>
<institution>Division of Pathology, National Institute of Health Sciences</institution>, <city>Kawasaki</city>, <state>Kanagawa</state>, <country country="JP">Japan</country>
</aff>
<aff id="aff3">
<label>3</label>
<institution>Advanced Materials &#x26; Solutions Research Laboratory, Research Center, Mitsui Chemicals, Inc.</institution>, <city>Mobara-shi, Chiba</city>, <country country="JP">Japan</country>
</aff>
<aff id="aff4">
<label>4</label>
<institution>Cell Culture Solution Department, New Business Incubation Center, Mitsui Chemicals, Inc.</institution>, <city>Chuo-ku, Tokyo</city>, <country country="JP">Japan</country>
</aff>
<aff id="aff5">
<label>5</label>
<institution>Institute for Advanced Biosciences, Keio University</institution>, <city>Tsuruoka</city>, <state>Yamagata</state>, <country country="JP">Japan</country>
</aff>
<aff id="aff6">
<label>6</label>
<institution>Department of Regulatory Science, Graduate School of Pharmaceutical Sciences, Nagoya City University</institution>, <city>Nagoya</city>, <country country="JP">Japan</country>
</aff>
<author-notes>
<corresp id="c001">
<label>&#x2a;</label>Correspondence: Hiroshi Arakawa, <email xlink:href="mailto:arakawa@phar.nagoya-cu.ac.jp">arakawa@phar.nagoya-cu.ac.jp</email>
</corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-06-25">
<day>25</day>
<month>06</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>8</volume>
<elocation-id>1838970</elocation-id>
<history>
<date date-type="received">
<day>25</day>
<month>03</month>
<year>2026</year>
</date>
<date date-type="rev-recd">
<day>22</day>
<month>05</month>
<year>2026</year>
</date>
<date date-type="accepted">
<day>31</day>
<month>05</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2026 Kadoguchi, Matsushita, Takahashi, Esashika, Yang, Sugimoto, Tamai and Arakawa.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Kadoguchi, Matsushita, Takahashi, Esashika, Yang, Sugimoto, Tamai and Arakawa</copyright-holder>
<license>
<ali:license_ref start_date="2026-06-25">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>Maintaining viability and physiological function in kidney tissue slice cultures remains a major challenge for <italic>ex vivo</italic> renal models, primarily due to limited oxygen diffusion into the tissue interior. In this study, we investigated whether shaking culture could improve the maintenance of primary rat kidney tissue slices.</p>
</sec>
<sec>
<title>Methods</title>
<p>Rat kidney tissue slices (200&#xa0;&#xb5;m) were cultured under static or shaking conditions for up to 7&#xa0;days. Tissue viability, histological features, renal transporter activity, nephrotoxic responses, and metabolomic profiles were evaluated.</p>
</sec>
<sec>
<title>Results</title>
<p>Shaking culture markedly improved tissue viability, as evidenced by sustained ATP levels over 7&#xa0;days compared with static conditions. Histological analysis revealed partial preservation of epithelial polarity, indicated by the maintained apical localization of aquaporin 1. Transporter studies demonstrated that uptake activities of Oat1/3 and Oct2 substrates were better preserved under shaking conditions. Furthermore, shaking-cultured slices enabled the evaluation of nephron segment&#x2013;specific injury, with cisplatin inducing tubular damage and puromycin or dasatinib affecting glomerular structures. Metabolomic analysis revealed distinct alterations in central carbon metabolism, including increased levels of tricarboxylic acid cycle intermediates, suggesting improved mitochondrial function.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>These findings demonstrate that shaking culture provides a simple and effective approach to improve the culture microenvironment, thereby improving the maintenance of viability and physiological function in kidney tissue slices. This system may serve as a useful platform for investigating renal pharmacokinetics and drug-induced kidney injury.</p>
</sec>
</abstract>
<kwd-group>
<kwd>DIKI</kwd>
<kwd>kidney</kwd>
<kwd>renal transporter</kwd>
<kwd>shaking culture</kwd>
<kwd>tissue culture</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. This study was supported by the Japanese Agency for Medical Research and Development (grant number JP20mk0101182h0001, JP23mk0121270h0001, and JP24be1004101), the Japan Society for the Promotion of Science KAKENHI (JP22K19372), and Mitsui Chemicals, Inc. Mitsui Chemicals provided materials used in this study. Mitsui Chemicals reviewed the manuscript only for minor factual corrections, such as material names. Mitsui Chemicals was not involved in the study design, collection, analysis, interpretation of data, the writing of this article, or the decision to submit it for publication.</funding-statement>
</funding-group>
<counts>
<fig-count count="5"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="34"/>
<page-count count="11"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>In Vitro Toxicology</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<label>1</label>
<title>Introduction</title>
<p>The kidney plays a central role in maintaining systemic homeostasis by regulating electrolyte balance, acid-base status, fluid volume, and the elimination of endogenous and xenobiotic compounds. It is a structurally complex organ composed of multiple specialized cell types, including glomerular cells responsible for filtration and tubular epithelial cells that carry out energy-intensive transport processes underlying the reabsorption and secretion of a wide range of solutes. In addition, other nephron segments, such as the loop of Henle, distal tubules, and collecting ducts, as well as interstitial cells, contribute to the coordinated regulation of renal function. Beyond its physiological importance, the kidney is a major organ involved in drug disposition and a frequent target of adverse drug reactions. This structural and functional complexity underlies the difficulty of reproducing renal physiology <italic>in vitro</italic>.</p>
<p>Experimental systems that enable mechanistic investigation of renal function are important in drug discovery and development, as renal transport processes are essential determinants of both pharmacokinetics and drug-induced toxicity. However, the development of physiologically relevant <italic>in vitro</italic> kidney models remains challenging (<xref ref-type="bibr" rid="B2">Arakawa et al., 2025</xref>). Conventional cell culture systems, including immortalized renal cell lines, often fail to capture the structural complexity and functional heterogeneity of the nephron. In particular, these models poorly reproduce the coordinated functions of multiple nephron segments and the transporter-mediated processes that are critical for renal drug handling.</p>
<p>Kidney tissue slices represent a promising experimental platform to address these limitations. Tissue slices preserve the native architecture of the kidney, including multiple nephron segments and diverse cell types within a shared tissue environment. This structural preservation enables investigation of renal transport processes and drug responses under conditions that more closely resemble those of the <italic>in vivo</italic> kidney. Despite these advantages, maintaining tissue viability and physiological function in kidney slice cultures remains technically challenging. A major limitation of organ slice culture systems is the limited diffusion of oxygen into the interior of the slice, reducing oxygen availability for cells located deeper within the tissue during culture. This diffusion limitation has been widely recognized in organ slice models of several tissues and represents a critical determinant of tissue survival and metabolic activity.</p>
<p>Adequate oxygen supply is particularly critical for kidney tissue, as renal tubular epithelial cells rely heavily on mitochondrial oxidative metabolism to generate the ATP required for active solute transport (<xref ref-type="bibr" rid="B4">Bhargava and Schnellmann, 2017</xref>). Insufficient oxygen delivery <italic>in vitro</italic> can therefore lead to rapid ATP depletion, loss of transporter activity, and deterioration of tissue viability. Several approaches have been proposed to improve oxygen availability in organ slice cultures, including oxygen-permeable culture substrates (<xref ref-type="bibr" rid="B1">Arakawa et al., 2022</xref>; <xref ref-type="bibr" rid="B16">Kadoguchi et al., 2026</xref>; <xref ref-type="bibr" rid="B8">Danoy et al., 2022</xref>; <xref ref-type="bibr" rid="B20">Nishikawa et al., 2022</xref>; <xref ref-type="bibr" rid="B30">Takemura et al., 2023</xref>; <xref ref-type="bibr" rid="B15">Ito et al., 2025</xref>) that enhance medium mixing. Among these strategies, shaking culture may represent a simple and practical method to improve oxygen supply by reducing diffusion limitation at the medium-tissue slice interface.</p>
<p>In the present study, we investigated whether shaking culture could improve the maintenance of viability and physiological function in primary rat kidney tissue slices. We evaluated tissue viability and functional activity in kidney tissue slices, suggesting that dynamic culture conditions provide a more favorable microenvironment for <italic>ex vivo</italic> renal tissue culture.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2-1">
<label>2.1</label>
<title>Materials</title>
<p>Cisplatin (cis-Diammineplatinum(II) Dichloride), dasatinib, and probenecid were purchased from Tokyo Chemical Industry (Tokyo, Japan). Cimetidine and puromycin aminonucleoside were purchased from FUJIFILM Wako Pure Chemical Corporation (Osaka, Japan). [3H]p-aminohippuric acid (PAH) and [14C]metformin were purchased from PerkinElmer (Waltham, MA, United States). Rabbit monoclonal anti-WT1 antibody (ab267377) and goat polyclonal anti-rabbit IgG (ab150081) were purchased from Abcam (Cambridge, United Kingdom). Mouse monoclonal anti-aquaporin 1 (Aqp1) antibody (clone: B-11; sc-25287) was purchased from Santa Cruz Biotechnology (Dallas, TX, United States). Goat polyclonal anti-kidney injury molecule-1 (Kim-1) antibody (AF3689) was purchased from R&#x26;D Systems (Minneapolis, MN, United States). Histofine Simple Stain MAX PO was purchased from Nichirei Bioscience, Inc. (Tokyo, Japan). The InnoCell&#x2122; non-treated 24-well plates were provided by Mitsui Chemicals, Inc. (Tokyo, Japan).</p>
</sec>
<sec id="s2-2">
<label>2.2</label>
<title>Animal</title>
<p>Male Wistar rats (7&#x2013;9&#xa0;weeks old) were purchased from Sankyo Labo Service Corporation Inc. (Hamamatsu, Japan). The rats were housed under controlled conditions (3 rats per cage, 12&#xa0;h light/dark cycles, temperature 24.0&#xa0;&#xb0;C &#xb1; 1&#xa0;&#xb0;C, humidity 55% &#xb1; 5%) and had free access to water and a standard diet throughout the experimental period. The Kanazawa University Institutional Animal Care and Use Committee and the Animal Experiment Ethics Committee of Nagoya City University Graduate School of Pharmaceutical Sciences approved all animal experiments. All protocols for animal experiments performed in the present study were approved by the committee (Approval Number: AP23-049 for Kanazawa University and 25-008H03 for Nagoya City University).</p>
</sec>
<sec id="s2-3">
<label>2.3</label>
<title>Primary culture of rat kidney tissue slices</title>
<p>Rat kidney tissue slices (200&#xa0;&#xb5;m thick) were prepared using a microslicer (Zero 1; Dosaka EM, Kyoto, Japan) as described previously (<xref ref-type="bibr" rid="B16">Kadoguchi et al., 2026</xref>). The slices were transferred into InnoCell&#x2122; non-treated 24-well plates prewarmed to 37&#xa0;&#xb0;C, containing 300&#xa0;&#xb5;L of Williams&#x2019; Medium E (Thermo Fisher Scientific, Waltham, MA, United States) supplemented with 5% (v/v) fetal bovine serum (Serana Europe GmbH, Brandenburg, Germany), 100 units/mL penicillin-streptomycin (Nacalai Tesque, Kyoto, Japan), 0.1% (v/v) dexamethasone, 1% (v/v) ITS Liquid Media Supplement (Sigma-Aldrich, St. Louis, MO, United States), and 2&#xa0;mM alanylglutamine (FUJIFILM Wako Pure Chemical Corporation) in the presence or absence of the test drugs. The slices were incubated at 37&#xa0;&#xb0;C in a humidified atmosphere containing 5% CO<sub>2</sub> for up to 7&#xa0;days, with the medium changed daily. The drugs were replenished with each medium replacement. Shaking culture was performed by incubating the culture plates on an orbital shaker (MINI WAVE, AS ONE Corporation, Osaka, Japan) placed inside a CO<sub>2</sub> incubator at the indicated rotational speeds (0, 10, 50, 100, 150&#xa0;rpm), with 0&#xa0;rpm used as the static control.</p>
</sec>
<sec id="s2-4">
<label>2.4</label>
<title>ATP assay</title>
<p>ATP content of rat kidney tissue slices was measured using the &#x201c;Tissue&#x201d; ATP Assay Kit (TOYO B-Net Co., Ltd., Tokyo, Japan) as described previously (<xref ref-type="bibr" rid="B1">Arakawa et al., 2022</xref>; <xref ref-type="bibr" rid="B16">Kadoguchi et al., 2026</xref>). Luminescence was measured using a microplate reader (Infinite200PRO; Tecan Group Ltd., M&#xe4;nnedorf, Switzerland). ATP content of the slices was normalized to slice weight.</p>
</sec>
<sec id="s2-5">
<label>2.5</label>
<title>Uptake study</title>
<p>Rat kidney tissue slices were pre-incubated with fresh transport buffer for 5&#xa0;min at 37&#xa0;&#xb0;C or 4&#xa0;&#xb0;C under oxygen bubbling. The transport buffer was then replaced with 1&#xa0;mL of transport buffer containing the test drug, and the mixture was incubated for 15&#xa0;min under oxygen bubbling. Uptake was terminated by washing the slices three times with ice-cold transport buffer. Slice weights were measured, and the slices were dissolved in 1N NaOH at 60&#xa0;&#xb0;C. After neutralization with 5N HCl, radioactivity was measured using a liquid scintillation counter (LSC-7200, ALOKA Co., Ltd., Tokyo, Japan).</p>
</sec>
<sec id="s2-6">
<label>2.6</label>
<title>Histopathological analysis</title>
<p>Histopathological procedures were described previously (<xref ref-type="bibr" rid="B16">Kadoguchi et al., 2026</xref>), with minor modifications. Rat kidney tissue slices were fixed with 10% Formaldehyde Neutral Buffer Solution (Nacalai Tesque) or methanol. The kidney tissue slices were embedded in paraffin and sectioned at 4&#xa0;&#xb5;m for hematoxylin-eosin (H&#x26;E) staining. For immunohistochemistry, sections were autoclaved for antigen retrieval, followed by blocking with 10% normal goat serum (AQP1) or rabbit serum (Kim-1), and then incubated at 4&#xa0;&#xb0;C overnight with antibodies targeting AQP1 (1:300) and Kim-1 (1:1,000). Subsequently, the sections were incubated with a horseradish peroxidase-conjugated antibody. The antibody reaction was visualized using 3,3&#x2032;-diaminobenzidine tetrahydrochloride. For WT-1 immunofluorescence staining, slices were incubated with 1% bovine serum albumin, followed by incubation with a rabbit monoclonal anti-WT1 antibody (1:100) overnight 4&#xa0;&#xb0;C. Subsequently, the slices were incubated with goat polyclonal anti-rabbit IgG antibody for 2&#xa0;h at room temperature. Fluorescence images were acquired using BZ-X810 (Keyence, Osaka, Japan).</p>
</sec>
<sec id="s2-7">
<label>2.7</label>
<title>Metabolome analysis</title>
<p>Rat kidney tissue slices cultured under static and shaking conditions for 3&#xa0;days were weighed into screw tubes and homogenized with zirconia beads (5&#xa0;mm &#xd7; 2, 3&#xa0;mm &#xd7; 4) in methanol containing the internal standards, D-camphor-10-sulfonic acid (CSA), 2-(N-morpholino)ethanesulfonic acid, and methionine sulfate. The detailed procedure was described previously (<xref ref-type="bibr" rid="B17">Kajiwara et al., 2024</xref>; <xref ref-type="bibr" rid="B21">Ohta et al., 2024</xref>). Briefly, absolute quantification was performed using capillary electrophoresis&#x2013;time-of-flight-mass spectrometry (CE-TOFMS). All samples were analyzed in a single batch to minimize potential batch effects. A mixture of standard compounds was measured within the same batch. Internal standards were included in both the biological samples and the standard mixture, and signal intensities were normalized using these internal standards to correct for run-to-run variation in MS sensitivity. Migration times in the CE system were also corrected using internal standards. Metabolite identification was performed based on matching authentic standards. <italic>m/z</italic> values were matched within a 10&#xa0;ppm tolerance, and migration times were aligned and matched within 0.1&#xa0;s after correction using internal standards. Isotopic patterns were also examined to exclude noise-derived signals. Metabolites that met these criteria were identified at MSI Level 1. It was confirmed that most detected peaks were within the linear range of the calibration curves.</p>
</sec>
<sec id="s2-8">
<label>2.8</label>
<title>Statistical analysis</title>
<p>Data are presented as the mean &#xb1; standard deviation (S.D.). Statistical significance was evaluated using Student&#x2019;s t-test or ANOVA, followed by a Tukey-Kramer test. A <italic>p</italic> &#x3c; 0.05 was considered statistically significant. Principal component analysis (PCA) and pathway analysis were performed using MetaboAnalyst ver. 6.0 (<ext-link ext-link-type="uri" xlink:href="https://www.metaboanalyst.ca/">https://www.metaboanalyst.ca/</ext-link>). For PCA, metabolite concentration data were log10-transformed and auto-scaled without sample normalization prior to analysis. For pathway analysis, quantitative metabolite concentration data were uploaded as a concentration table without additional normalization, transformation, or scaling. Pathway enrichment analysis was conducted using the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway library for <italic>Rattus norvegicus</italic> (rat) using the quantitative enrichment analysis (QEA) framework together with pathway topology analysis. MetaboAnalyst-generated pathway visualization plots were based on raw p-values according to the default software setting, while false discovery rate (FDR)-adjusted p-values were also calculated and considered during data interpretation.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<label>3</label>
<title>Results</title>
<sec id="s3-1">
<label>3.1</label>
<title>Shaking culture preserves viability of rat kidney tissue slices</title>
<p>The effects of shaking culture on the viability of primary cultured rat kidney tissue slices were evaluated. Tissue slices were cultured for 7&#xa0;days under static (0&#xa0;rpm) or shaking conditions (20, 50, 100, and 150&#xa0;rpm), and viability was evaluated by measuring intratissue ATP levels. ATP levels in slices cultured at 100 or 150&#xa0;rpm remained comparable to those measured immediately after isolation throughout the 7-day culture period (<xref ref-type="fig" rid="F1">Figure 1</xref>). Based on these results, subsequent experiments were performed at 100&#xa0;rpm.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Viability of rat kidney tissue slices cultured under static and shaking conditions. Rat kidney tissue slices were cultured under static or shaking conditions (0, 20, 50, 100, 150&#xa0;rpm) for 7&#xa0;days. Tissue viability was assessed by measuring ATP content. Data are represented as mean &#xb1; S.D. (n &#x3d; 3&#x2013;6). &#x2a; indicates statistically significant differences from the static conditions (<italic>p</italic> &#x3c; 0.05, Tukey-Kramer test).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="ftox-08-1838970-g001.tif">
<alt-text content-type="machine-generated">Text &#x2013; Line graph depicting intratissue ATP percentage over seven days across different shaking speeds 150, 100, 50, 20, and 0. Higher shaking speeds groups maintain higher intratissue ATP levels.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-2">
<label>3.2</label>
<title>Effects of shaking culture on the histological features of kidney tissue slices</title>
<p>The effects of shaking culture on tissue structure and protein localization were examined by histological analysis. Kidney tissue slices were cultured under static and shaking conditions for 3 or 7&#xa0;days, then stained with H&#x26;E and immunostained for AQP1. H&#x26;E staining revealed no remarkable differences in tissue structure between the static and shaking culture conditions (<xref ref-type="fig" rid="F2">Figure 2a</xref>). In both culture conditions, regenerated tubules were observed on the cut surface of the tissue slice. Immunohistochemistry of AQP1 showed that AQP1 expression gradually decreased with increasing culture duration under both culture conditions over 7-day culture period (<xref ref-type="fig" rid="F2">Figure 2b</xref>). However, slices cultured under shaking conditions maintained relatively stronger apical localization of AQP1 compared with slices cultured under static conditions (<xref ref-type="fig" rid="F2">Figure 2b</xref>). These results suggest that shaking culture better preserves proximal tubular polarity during culture.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Histological features of primary cultured rat kidney tissue in static and shaking conditions. Histological analysis <bold>(a)</bold> and immunohistochemical staining for aquaporin 1 (AQP1) <bold>(b)</bold> were performed on primary cultured rat kidney tissue slices under static and shaking conditions for 3 and 7&#xa0;days. Arrowheads indicate regenerative tubules.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="ftox-08-1838970-g002.tif">
<alt-text content-type="machine-generated">Panel a shows five microscopic images of H&#x0026;E staining of kidney tissue slices across three timepoints (Day 0, Day 3, Day 7) under static and shaking conditions. Panel b displays five corresponding images stained for AQP1.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-3">
<label>3.3</label>
<title>Effects of shaking culture on drug transporter activity in primary cultured rat kidney tissue slices</title>
<p>To examine the effects of shaking culture on renal drug transporter activities, uptake studies were performed using Oat1/3 substrate PAH and Oct2 substrate metformin. In freshly isolated slices (Day 0), PAH uptake was 3.56 &#xb1; 0.85&#xa0;&#x3bc;L/mg kidney. Co-incubation with probenecid, an Oat1/3 inhibitor, significantly reduced PAH uptake to 1.56 &#xb1; 0.13&#xa0;&#x3bc;L/mg kidney, confirming functional Oat1/3 transport activity. After 2&#xa0;days of static culture, PAH uptake decreased to 1.05 &#xb1; 0.18&#xa0;&#x3bc;L/mg kidney, and uptake levels were similar to those observed in the presence of probenecid and 4&#xa0;&#xb0;C, indicating loss of transport activity. In contrast, slices cultured under shaking conditions for 2&#xa0;days exhibited higher PAH uptake (1.62 &#xb1; 0.19&#xa0;&#x3bc;L/mg kidney), which was significantly reduced to 1.10 &#xb1; 0.13&#xa0;&#x3bc;L/mg kidney by probenecid (31.8%), suggesting that shaking culture partially preserves Oat1/3-mediated transport activity.</p>
<p>Metformin uptake showed a similar trend. In freshly isolated slices, metformin uptake was 3.85 &#xb1; 0.53&#xa0;&#x3bc;L/mg kidney and was significantly reduced to 1.48 &#xb1; 0.43&#xa0;&#x3bc;L/mg kidney (<xref ref-type="fig" rid="F3">Figure 3a</xref>) by co-incubation with the Oct2 inhibitor cimetidine, confirming functional Oct2 transport activity. After 2&#xa0;days of static culture, metformin uptake was not significantly different from that observed in the presence of cimetidine or 4&#xa0;&#xb0;C. In contrast, slices cultured under shaking conditions exhibited metformin uptake (0.82 &#xb1; 0.20&#xa0;&#x3bc;L/mg kidney), which was significantly reduced to 0.41 &#xb1; 0.15&#xa0;&#x3bc;L/mg kidney by cimetidine (<xref ref-type="fig" rid="F3">Figure 3b</xref>). Although transporter activity decreased compared with freshly isolated slices, these results suggest that shaking culture better preserves drug transporter activity than static culture.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Transporter-mediated uptake in primary cultured rat kidney tissue slices. Uptake of [<sup>3</sup>H]PAH (45&#xa0;nM; 0.18&#xa0;&#x3bc;Ci/mL) <bold>(a)</bold> and [<sup>14</sup>C]metformin (60&#xa0;nM; 0.18&#xa0;&#x3bc;Ci/mL) <bold>(b)</bold> by primary cultured rat kidney tissue slices in static and shaking (100&#xa0;rpm) conditions. Uptake was evaluated in the absence or presence of probenecid (1&#xa0;mM) or cimetidine (1&#xa0;mM) at 37&#xa0;&#xb0;C or 4&#xa0;&#xb0;C for 15&#xa0;min. Data are represented as mean &#xb1; S.D. (n &#x3d; 3&#x2013;6). &#x2a; indicates statistically significant differences from the control group (<italic>p</italic> &#x3c; 0.05, Tukey-Kramer test).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="ftox-08-1838970-g003.tif">
<alt-text content-type="machine-generated">Panel a shows [3H]PAH uptake via Oat1/3 and panel b shows [14C]metformin uptake via Oct2 in kidney tissue slices under shaking and static culture conditions, in the absence or presence of each inhibitor at 37 &#x00B0;C or 4 &#x00B0;C. Shaking culture maintains higher uptake activity compared with static culture.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-4">
<label>3.4</label>
<title>DIKI evaluation using rat kidney tissue slices cultured under shaking conditions</title>
<p>To evaluate DIKI across different nephron segments, kidney slices were exposed for 2&#xa0;days to cisplatin, which induces tubular toxicity, and to puromycin and dasatinib, which induce glomerular toxicity. Subsequently, H&#x26;E staining and immunostaining were performed. In the cisplatin group, H&#x26;E staining revealed concentration-dependent tissue disruption (<xref ref-type="fig" rid="F4">Figure 4a</xref>). In addition, the number of regenerative tubules observed at the cut surface of the tissue slices decreased in a cisplatin concentration-dependent manner. In particular, the number of regenerative tubules decreased with increasing cisplatin concentrations from 1 to 10&#xa0;&#xb5;M. Therefore, Kim-1 immunostaining, a tubule regeneration marker, was performed at the intermediate concentration of 3&#xa0;&#xb5;M because this condition was considered suitable for clearer histological evaluation of tubular regenerative changes. Both H&#x26;E staining and Kim-1 immunostaining revealed decreased regenerated tubular structures following cisplatin exposure. These findings suggest that cisplatin suppressed tubular regeneration as a consequence of tubular injury. For the evaluation of glomerular toxicity, immunostaining for Wilms&#x2019; tumor-1 (WT1), a nuclear transcription factor involved in maintaining the glomerular structure and function (<xref ref-type="bibr" rid="B22">Palmer et al., 2001</xref>; <xref ref-type="bibr" rid="B13">Guo, 2002</xref>; <xref ref-type="bibr" rid="B32">Wagner et al., 2004</xref>), was performed after exposure to puromycin and dasatinib (<xref ref-type="fig" rid="F4">Figure 4b</xref>). Changes in WT1 staining indicated glomerular injury in these treatment groups. Collectively, these results demonstrate that rat kidney tissue slices cultured under shaking conditions allow simultaneous evaluation of nephron segment&#x2013;specific injury.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Evaluation of cisplatin-, puromycin-, and dasatinib-induced kidney injury by primary rat kidney tissue slices. <bold>(a)</bold> H&#x26;E staining and immunohistochemical staining for Kim-1 in primary cultured rat kidney tissue slices in absence or presence of cisplatin (0.1, 1, 3, 10, 100 &#x03BC;M) for 2 or 3 days. White arrowheads indicate regenerative tubules. <bold>(b)</bold> Immunofluorescence staining for WT1 in primary cultured rat kidney tissue slices in the absence or presence of puromycin (100&#xa0;&#xb5;M) and dasatinib (2&#xa0;&#xb5;M) for 2&#xa0;days. Nuclei were counterstained with Hoechst33342. White arrowheads indicate glomeruli.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="ftox-08-1838970-g004.tif">
<alt-text content-type="machine-generated">Panel a shows H&#x0026;E and KIM-1 stained tissue sections under increasing cisplatin concentrations, demonstrating dose-dependent tissue injury following cisplatin exposure. Panel b shows WT1 immunostaining in tissue exposed to puromycin and dasatinib, both of which induce podocyte-specific renal injury; decreased WT1 expression is observed in drug-exposed groups compared with controls.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-5">
<label>3.5</label>
<title>Shaking culture alters the metabolic profiles of kidney tissue slices</title>
<p>To explore the metabolic changes associated with shaking culture, metabolic analysis was performed on rat kidney tissue slices under static and shaking conditions for 2&#xa0;days. As a result, a total of 134 metabolites were detected (<xref ref-type="sec" rid="s12">Supplementary Table S1</xref>). Samples from the shaking and static culture conditions were clearly separated in the score plot (<xref ref-type="fig" rid="F5">Figure 5a</xref>). PCA revealed a clear separation between static and shaking conditions along PC1 (56.9%), indicating that culture conditions were the primary source of metabolic variation (<xref ref-type="fig" rid="F5">Figure 5a</xref>). Each point represents an individual sample. Notably, samples under static conditions exhibited greater dispersion than those under shaking conditions, suggesting increased metabolic variability. In contrast, samples from the shaking conditions were more tightly clustered, indicating improved reproducibility and more stable metabolic profiles.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Metabolome analysis of primary cultured rat kidney tissue slices. <bold>(a)</bold> Principal component analysis (PCA) of metabolomic profiles in primary cultured rat kidney tissue slices. Each dot represents an individual kidney tissue slice sample. Colors indicate experimental groups, static (green) and shaking (red). Each dot represents an individual sample. PC1 (56.9%) and PC2 (18.7%) indicate the proportion of total variance explained by each principal component. The shaded areas represent the 95% confidence intervals for each group (static and shaking conditions). The kidney tissue slice samples shown in the PCA plots represent technical replicates derived from the same biological samples, in which individual kidney tissue slices obtained from the same animal were cultured independently in separate wells. <bold>(b)</bold> Pathway significantly altered in primary cultured kidney tissue slices between static and shaking conditions. The x-axis indicates pathway impact, and the y-axis shows statistical significance expressed as &#x2212;log10 (p-value). Each dot represents a metabolic pathway.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="ftox-08-1838970-g005.tif">
<alt-text content-type="machine-generated">Panel a shows a principal component analysis of kidney tissue slices cultured under shaking or static conditions. Panel b shows pathway analysis. Shaking culture alters metabolic profiles of kidney tissue slices.</alt-text>
</graphic>
</fig>
<p>Compared with static culture, 42 metabolites were significantly increased, and 5 metabolites were significantly decreased under shaking culture conditions after FDR correction (<xref ref-type="sec" rid="s12">Supplementary Figure S1</xref>). Pathway analysis indicated significant alterations in pathways related to central carbon metabolism (<xref ref-type="fig" rid="F5">Figure 5b</xref>; <xref ref-type="sec" rid="s12">Supplementary Table S2</xref>). In particular, the tricarboxylic acid (TCA) cycle intermediates malate and fumarate were significantly higher in slices cultured under shaking conditions than in static culture. Although the glycolysis/gluconeogenesis pathway did not reach statistical significance at the pathway level (P &#x3d; 0.060), several metabolites associated with this pathway were significantly altered under shaking culture conditions. Specifically, the levels of 3-phosphoglycerate (3PG), glucose-6-phosphate (G6P), and glucose-1-phosphate (G1P) were significantly higher than in static culture. These findings suggest that shaking culture may influence central carbon metabolism.</p>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<label>4</label>
<title>Discussion</title>
<p>Maintaining viability and physiological function in kidney tissue slice cultures remains a major challenge for <italic>ex vivo</italic> renal models. In the present study, shaking culture markedly improved the preservation of rat kidney tissue slices, as demonstrated by sustained ATP levels, partial maintenance of renal transporter activity, preserved responsiveness to nephrotoxic drugs, and metabolic changes associated with energy metabolism. These results indicate that dynamic culture conditions provide a more favorable microenvironment for maintaining functional kidney tissue slices compared with static culture.</p>
<p>First, shaking culture significantly improved the maintenance of tissue viability, as evidenced by sustained ATP levels for up to 7&#xa0;days (<xref ref-type="fig" rid="F1">Figure 1</xref>). Our previous study using oxygen-permeable plates under static culture conditions partially attenuated ATP depletion in kidney tissue slices (<xref ref-type="bibr" rid="B1">Arakawa et al., 2022</xref>; <xref ref-type="bibr" rid="B16">Kadoguchi et al., 2026</xref>). However, even with oxygen-permeable plates, ATP levels remained at approximately 50% of those observed in freshly isolated kidney tissues, indicating that oxygen-permeable plates alone were insufficient to fully preserve tissue viability during prolonged culture. In contrast, the present study demonstrated that combining oxygen-permeable plates with shaking culture maintained intratissue ATP levels throughout the 7-day culture period. These findings suggest that shaking culture may complement oxygen-permeable culture systems by further improving the culture microenvironment. Renal tubular epithelial cells have high metabolic demands and rely heavily on mitochondrial oxidative phosphorylation to generate the ATP required for active solute transport (<xref ref-type="bibr" rid="B4">Bhargava and Schnellmann, 2017</xref>). In organ slice culture systems, oxygen must diffuse from the culture medium into the interior of the slice, which can limit oxygen availability in deeper regions of the tissue. The effective oxygen diffusion distance in biological tissues is generally estimated to be approximately 100&#x2013;300&#xa0;&#xb5;m (<xref ref-type="bibr" rid="B9">De Graaf et al., 2010</xref>; <xref ref-type="bibr" rid="B12">Fisher and Vickers, 2013</xref>; <xref ref-type="bibr" rid="B14">Humpel, 2015</xref>; <xref ref-type="bibr" rid="B19">Neuhaus et al., 2017</xref>; <xref ref-type="bibr" rid="B10">Dewyse et al., 2021</xref>; <xref ref-type="bibr" rid="B23">Preu&#xdf; et al., 2022</xref>; <xref ref-type="bibr" rid="B29">Siwczak et al., 2023</xref>). Therefore, cells located farther from the slice surface may experience reduced oxygen availability under static culture conditions. The improved ATP maintenance observed under shaking conditions suggests that dynamic culture may enhance oxygen and nutrient supply by promoting medium mixing and reducing diffusion limitations at the medium-tissue slice interface.</p>
<p>Slice thickness is another important factor affecting oxygen diffusion and tissue viability in organ slice cultures. In the present study, kidney tissue slices with a thickness of 200&#xa0;&#xb5;m were used. In preliminary experiments, thinner slices (approximately 100&#xa0;&#xb5;m) were also prepared; however, regions lacking glomeruli were frequently observed, indicating that thin slices may not adequately represent the full renal microarchitecture. Moreover, the thinner slices were more fragile and prone to mechanical damage during handling. These observations suggest that although thinner slices may theoretically improve oxygen and drug diffusion, excessively thin slices may compromise structural integrity and experimental reproducibility. Therefore, the use of 200&#xa0;&#xb5;m slices likely represents a practical balance between maintaining tissue architecture and ensuring adequate oxygen supply.</p>
<p>Histopathological analysis indicated that shaking culture partially preserved tissue structure and epithelial polarity (<xref ref-type="fig" rid="F2">Figure 2a</xref>). Although overall tissue architecture was maintained under both culture conditions, apical localization of AQP1 was relatively better preserved in slices cultured under shaking conditions (<xref ref-type="fig" rid="F2">Figure 2b</xref>). Renal tubular epithelial cells possess highly polarized structures that are essential for vectorial solute transport, and disruption of cellular polarity is commonly associated with ATP depletion and cytoskeletal disorganization in proximal tubular cells (<xref ref-type="bibr" rid="B5">Bush et al., 2000</xref>; <xref ref-type="bibr" rid="B27">Schl&#xfc;ter and Margolis, 2012</xref>). Therefore, the improved preservation of ATP levels in kidney tissue slices under shaking culture conditions may partly contribute to the maintenance of epithelial polarity during <italic>ex vivo</italic> culture.</p>
<p>In addition to structural preservation, shaking culture also partially maintained renal drug transporter activity (<xref ref-type="fig" rid="F3">Figure 3</xref>). Because renal transporter function is closely associated with transporter-mediated nephrotoxicity, preservation of transporter activity during culture is important for evaluating nephrotoxic responses in kidney tissue slices. Our previous study demonstrated that nephrotoxic responses were more clearly detectable after 48-h exposure than after 24-h exposure (<xref ref-type="bibr" rid="B1">Arakawa et al., 2022</xref>). Therefore, maintenance of transporter activity for at least 2&#xa0;days was considered important for transporter-related nephrotoxicity assessment in cultured kidney tissue slices. Transporters such as OAT1/3 and OCT2 are key determinants of renal drug secretion and play important roles in renal pharmacokinetics and drug-induced nephrotoxicity (<xref ref-type="bibr" rid="B34">Yokoo et al., 2007</xref>; <xref ref-type="bibr" rid="B11">Filipski et al., 2009</xref>; <xref ref-type="bibr" rid="B7">Ciarimboli et al., 2010</xref>; <xref ref-type="bibr" rid="B18">Nakamura et al., 2010</xref>; <xref ref-type="bibr" rid="B26">Sauzay et al., 2016</xref>; <xref ref-type="bibr" rid="B31">Uwai et al., 2007</xref>; <xref ref-type="bibr" rid="B3">Bam et al., 2014</xref>; <xref ref-type="bibr" rid="B2">Arakawa et al., 2025</xref>). Loss of transporter activity during culture is a well-known limitation of kidney slice models. In the present study, the uptake of PAH, an Oat1/3 substrate, and metformin, an Oct2 substrate, was better preserved in slices cultured under shaking conditions than in static culture, suggesting that dynamic culture conditions may help maintain transporter activity. The uptake activities after culture were approximately 46% of Day 0 levels for PAH and approximately 21% for metformin under shaking conditions, indicating a partial decline in transporter function during culture. In addition, AQP1 immunostaining showed reduced apical localization after culture compared with Day 0. These findings suggest that, although overall tissue viability was maintained, tubular epithelial cell differentiation and polarity were only partially preserved under the current culture conditions. Because transporter localization and activity are closely associated with epithelial polarity, disruption of tubular architecture during culture may have contributed to the reduced transporter function observed after prolonged incubation. Nevertheless, transporter-mediated uptake remained clearly detectable and significantly higher than that observed under static conditions. These findings suggest that the shaking culture method may be useful for comparative or qualitative evaluation of transporter-related responses in kidney tissue slices, although further optimization of culture conditions will be necessary to better preserve transporter localization and activity during prolonged culture.</p>
<p>Importantly, the present kidney tissue slice culture system also enables the evaluation of nephron segment-specific injury. For nephrotoxicity assessment, kidney tissue slices were exposed to test compounds for 48&#xa0;h because decreases in intratissue ATP levels were not consistently observed after 24-h exposure, whereas exposure for 48&#xa0;h or longer enabled detection of toxic responses. Exposure to cisplatin resulted in concentration-dependent inhibition of tubular regeneration (<xref ref-type="fig" rid="F4">Figure 4a</xref>), whereas puromycin and dasatinib induced alterations in WT1 staining (<xref ref-type="fig" rid="F4">Figure 4b</xref>), indicative of glomerular injury (<xref ref-type="bibr" rid="B25">Rico et al., 2005</xref>; <xref ref-type="bibr" rid="B33">Yan et al., 2012</xref>; <xref ref-type="bibr" rid="B28">Shen et al., 2016</xref>; <xref ref-type="bibr" rid="B6">Calizo et al., 2019</xref>). These findings suggest that kidney tissue slices cultured under shaking conditions retain sufficient structural and functional integrity to allow simultaneous assessment of tubular and glomerular toxicity. Because many forms of DIKI involve segment-specific mechanisms (<xref ref-type="bibr" rid="B24">Ricci and Ronco, 2012</xref>), the ability to evaluate different nephron segments within a single experimental system represents a key advantage of this model. However, further validation using a broader range of compounds and additional glomerular functional markers, such as nephrin and podocin, will be necessary. Moreover, ultrastructural analysis using electron microscopy may further clarify glomerular structural alterations in cultured kidney tissue slices. On the other hand, although albumin leakage is widely used as a clinical indicator of glomerular dysfunction, direct evaluation of albumin leakage is difficult in kidney tissue slice culture systems because glomerular filtration cannot be fully reproduced under the present <italic>ex vivo</italic> culture conditions. Furthermore, direct comparison of glomerular injury responses between static and shaking culture conditions was not performed in the present study. Therefore, although the present study demonstrated that glomerular injury responses could be evaluated under shaking culture conditions, the superiority of shaking culture for glomerular toxicity assessment remains to be established. Overall, these findings suggest the potential utility of shaking cultured kidney tissue slices as a platform for evaluating renal toxicity and pharmacokinetics.</p>
<p>Metabolomic analysis revealed alterations in central carbon metabolism under shaking culture conditions. Day 3 was selected for metabolomic analysis to better characterize metabolic differences between static and shaking culture conditions. At this time point, differences in intratissue ATP levels between the two culture conditions were more pronounced while the tissue still retained measurable viability during the extended culture period. Concentrations of TCA cycle intermediates, such as malate and fumarate, were increased (<xref ref-type="fig" rid="F5">Figure 5b</xref>; <xref ref-type="sec" rid="s12">Supplementary Tables S1, S2</xref>). These findings suggest that mitochondrial metabolic activity may be better maintained under shaking conditions. Because mitochondrial oxidative metabolism is essential for ATP production in renal tubular cells, improved maintenance of mitochondrial metabolism may contribute to the sustained viability observed in shaking culture. In the PCA score plots, samples cultured under static conditions exhibited greater dispersion than those under shaking conditions, indicating greater metabolic heterogeneity. This variability may reflect uneven oxygen and nutrient distribution within the tissue slices under static conditions, leading to heterogeneous metabolic states across samples. In contrast, the tighter clustering observed under shaking conditions suggests a more uniform metabolic environment, likely due to improved medium mixing and oxygen availability. Such a reduction in metabolic variability is particularly important for experimental reproducibility and may enhance the reliability of this model for pharmacokinetic and toxicological evaluations.</p>
<p>Several limitations of the present study should be acknowledged. First, oxygen concentrations within the culture system were not directly measured. Although the improved ATP maintenance observed under shaking conditions is consistent with enhanced oxygen availability, this interpretation remains speculative without direct assessment of oxygen status or hypoxia-related markers. In addition, shaking culture may contribute to intratissue ATP preservation through multiple mechanisms, including improved nutrient delivery, waste removal, and mechanosensitive responses induced by medium circulation. Therefore, the precise mechanism underlying ATP preservation in kidney tissue slices remains unclear. Further studies using oxygen sensors or microelectrodes, together with evaluation of hypoxia-related markers such as HIF-1&#x3b1;, will be necessary to clarify the contribution of oxygen availability and other physical factors to energy homeostasis in kidney tissue slices. One additional limitation of the present study is that cultured slice viability was evaluated primarily based on intratissue ATP levels, whereas complementary cytotoxicity markers such as lactate dehydrogenase (LDH) release were not assessed. Although ATP content is widely used as an indicator of metabolic activity and tissue viability, additional evaluation of membrane integrity using LDH release assays would further strengthen the assessment of tissue injury and viability in cultured kidney tissue slices. Future studies incorporating multiple viability and cytotoxicity markers will therefore be necessary to further validate the culture system. Second, this study was performed using rat kidney tissue slices, and further studies are necessary to determine whether similar improvements can be achieved in human kidney tissue models. Despite these limitations, our findings demonstrate that shaking culture improves the maintenance of viability and functional activity in kidney tissue slices. This improved culture system may provide a useful experimental platform for studying renal drug transport, renal metabolism, and potentially DIKI <italic>in vitro</italic>. The metabolomic pathway results were visualized using the default raw p-value output from MetaboAnalyst, and FDR-adjusted values were also examined during interpretation. Given the inherent biological and technical variability in metabolomic datasets, these pathway findings should be considered exploratory and hypothesis-generating rather than definitive evidence of pathway dysregulation.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s12">Supplementary Material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec sec-type="ethics-statement" id="s6">
<title>Ethics statement</title>
<p>The animal study was approved by The Kanazawa University Institutional Animal Care and Use Committee and the Animal Experiment Ethics Committee of Nagoya City University Graduate School of Pharmaceutical Sciences approved all animal experiments. All protocols for animal experiments performed in the present study were approved by the committee (Approval Number: AP23-049 for Kanazawa University and 25-008H03 for Nagoya City University). The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec sec-type="author-contributions" id="s7">
<title>Author contributions</title>
<p>MK: Investigation, Visualization, Conceptualization, Formal Analysis, Validation, Writing &#x2013; original draft, Methodology. KM: Investigation, Writing &#x2013; review and editing, Methodology. JT: Resources, Writing &#x2013; review and editing, Methodology. KE: Resources, Writing &#x2013; review and editing, Methodology. JY: Resources, Methodology, Writing &#x2013; review and editing. MS: Investigation, Writing &#x2013; review and editing, Formal Analysis. IT: Writing &#x2013; review and editing, Supervision. HA: Funding acquisition, Project administration, Writing &#x2013; original draft, Supervision, Conceptualization, Writing &#x2013; review and editing.</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of interest</title>
<p>Authors JT, KE and JY were employed by Mitsui Chemicals, Inc.</p>
<p>The remaining author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s10">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="s12">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/ftox.2026.1838970/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/ftox.2026.1838970/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.pdf" id="SM1" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table1.xlsx" id="SM2" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arakawa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nagao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nedachi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shirasaka</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tamai</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Evaluation of platinum anticancer drug-induced kidney injury in primary culture of rat kidney tissue slices by using gas-permeable plates</article-title>. <source>Biol. Pharm. Bull.</source> <volume>45</volume>, <fpage>316</fpage>&#x2013;<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1248/bpb.b21-00875</pub-id>
</mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arakawa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Matsushita</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ishiguro</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>Advanced <italic>in vitro</italic> evaluation of drug-induced kidney injury using microphysiological systems in drug discovery and development</article-title>. <source>Drug Metab. Pharmacokinet.</source> <volume>61</volume>, <fpage>101056</fpage>. <pub-id pub-id-type="doi">10.1016/j.dmpk.2025.101056</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bam</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Yant</surname>
<given-names>S. R.</given-names>
</name>
<name>
<surname>Cihlar</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Tenofovir alafenamide is not a substrate for renal organic anion transporters (oats) and does not exhibit oat-dependent cytotoxicity</article-title>. <source>Antivir. Ther.</source> <volume>19</volume>, <fpage>687</fpage>&#x2013;<lpage>692</lpage>. <pub-id pub-id-type="doi">10.3851/IMP2770</pub-id>
<pub-id pub-id-type="pmid">24699134</pub-id>
</mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhargava</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Schnellmann</surname>
<given-names>R. G.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Mitochondrial energetics in the kidney</article-title>. <source>Nat. Rev. Nephrol.</source> <volume>13</volume>, <fpage>629</fpage>&#x2013;<lpage>646</lpage>. <pub-id pub-id-type="doi">10.1038/nrneph.2017.107</pub-id>
<pub-id pub-id-type="pmid">28804120</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bush</surname>
<given-names>K. T.</given-names>
</name>
<name>
<surname>Tsukamoto</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nigam</surname>
<given-names>S. K.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Selective degradation of E-cadherin and dissolution of E-cadherin-catenin complexes in epithelial ischemia</article-title>. <source>Am. J. Physiol. Ren. Physiol.</source> <volume>278</volume>, <fpage>F847</fpage>&#x2013;<lpage>F852</lpage>. <pub-id pub-id-type="doi">10.1152/ajprenal.2000.278.5.F847</pub-id>
<pub-id pub-id-type="pmid">10807598</pub-id>
</mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calizo</surname>
<given-names>R. C.</given-names>
</name>
<name>
<surname>Bhattacharya</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Van Hasselt</surname>
<given-names>J. G. C.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Wiener</surname>
<given-names>R. J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Disruption of podocyte cytoskeletal biomechanics by dasatinib leads to nephrotoxicity</article-title>. <source>Nat. Commun.</source> <volume>10</volume>, <fpage>2061</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-019-09936-x</pub-id>
<pub-id pub-id-type="pmid">31053734</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ciarimboli</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Deuster</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Knief</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sperling</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Holtkamp</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Edemir</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Organic cation transporter 2 mediates cisplatin-induced Oto- and nephrotoxicity and is a target for protective interventions</article-title>. <source>Am. J. Pathol.</source> <volume>176</volume>, <fpage>1169</fpage>&#x2013;<lpage>1180</lpage>. <pub-id pub-id-type="doi">10.2353/ajpath.2010.090610</pub-id>
<pub-id pub-id-type="pmid">20110413</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Danoy</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Scheidecker</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Arakawa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Esashika</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ishida</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Cryopreserved human hepatocytes culture optimization on polymethylpentene oxygen permeable membranes for drug screening purposes</article-title>. <source>Fundam. Toxicol. Sci.</source> <volume>9</volume>, <fpage>135</fpage>&#x2013;<lpage>144</lpage>. <pub-id pub-id-type="doi">10.2131/fts.9.135</pub-id>
</mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Graaf</surname>
<given-names>I. A. M.</given-names>
</name>
<name>
<surname>Olinga</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>De Jager</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Merema</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>De Kanter</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Van De Kerkhof</surname>
<given-names>E. G.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies</article-title>. <source>Nat. Protoc.</source> <volume>5</volume>, <fpage>1540</fpage>&#x2013;<lpage>1551</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2010.111</pub-id>
<pub-id pub-id-type="pmid">20725069</pub-id>
</mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dewyse</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Reynaert</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Van Grunsven</surname>
<given-names>L. A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Best practices and progress in precision-cut liver slice cultures</article-title>. <source>IJMS</source> <volume>22</volume>, <fpage>7137</fpage>. <pub-id pub-id-type="doi">10.3390/ijms22137137</pub-id>
</mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Filipski</surname>
<given-names>K. K.</given-names>
</name>
<name>
<surname>Mathijssen</surname>
<given-names>R. H.</given-names>
</name>
<name>
<surname>Mikkelsen</surname>
<given-names>T. S.</given-names>
</name>
<name>
<surname>Schinkel</surname>
<given-names>A. H.</given-names>
</name>
<name>
<surname>Sparreboom</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity</article-title>. <source>Clin. Pharmacol. Ther.</source> <volume>86</volume>, <fpage>396</fpage>&#x2013;<lpage>402</lpage>. <pub-id pub-id-type="doi">10.1038/clpt.2009.139</pub-id>
<pub-id pub-id-type="pmid">19625999</pub-id>
</mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fisher</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Vickers</surname>
<given-names>A. E. M.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Preparation and culture of precision-cut organ slices from human and animal</article-title>. <source>Xenobiotica</source> <volume>43</volume>, <fpage>8</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.3109/00498254.2012.728013</pub-id>
<pub-id pub-id-type="pmid">23030812</pub-id>
</mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>J.-K.</given-names>
</name>
<name>
<surname>Menke</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Gubler</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hammes</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2002</year>). <article-title>WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis</article-title>. <source>Hum. Mol. Genet.</source> <volume>11</volume>, <fpage>651</fpage>&#x2013;<lpage>659</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/11.6.651</pub-id>
<pub-id pub-id-type="pmid">11912180</pub-id>
</mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Humpel</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Organotypic brain slice cultures: a review</article-title>. <source>Neuroscience</source> <volume>305</volume>, <fpage>86</fpage>&#x2013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.07.086</pub-id>
<pub-id pub-id-type="pmid">26254240</pub-id>
</mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ito</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kawauchi</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Yanagita</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sakai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nishikawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Arakawa</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2025</year>). <article-title>Microphysiological systems for realizing microenvironment that mimics human physiology&#x2014;functional material and its standardization applied to microfluidics</article-title>. <source>Emergent Mater</source> <volume>8</volume>, <fpage>1139</fpage>&#x2013;<lpage>1151</lpage>. <pub-id pub-id-type="doi">10.1007/s42247-024-00822-x</pub-id>
</mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kadoguchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Matsushita</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Esashika</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tamai</surname>
<given-names>I.</given-names>
</name>
<etal/>
</person-group> (<year>2026</year>). <article-title>Evaluation of drug-induced kidney injury by primary culture of Rat kidney tissue slices using oxygen-permeable polyolefin plate with low drug adsorption</article-title>. <source>Biol. Pharm. Bull.</source> <volume>49</volume>, <fpage>122</fpage>&#x2013;<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1248/bpb.b25-00572</pub-id>
</mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kajiwara</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kakihana</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Maeda</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kaneko</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ota</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Enomoto</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Salivary metabolomic biomarkers for non&#x2010;invasive lung cancer detection</article-title>. <source>Cancer Sci.</source> <volume>115</volume>, <fpage>1695</fpage>&#x2013;<lpage>1705</lpage>. <pub-id pub-id-type="doi">10.1111/cas.16112</pub-id>
</mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakamura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yonezawa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hashimoto</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Katsura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Inui</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Disruption of multidrug and toxin extrusion MATE1 potentiates cisplatin-induced nephrotoxicity</article-title>. <source>Biochem. Pharmacol.</source> <volume>80</volume>, <fpage>1762</fpage>&#x2013;<lpage>1767</lpage>. <pub-id pub-id-type="doi">10.1016/j.bcp.2010.08.019</pub-id>
<pub-id pub-id-type="pmid">20813096</pub-id>
</mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neuhaus</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Schaudien</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Golovina</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Temann</surname>
<given-names>U.-A.</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lippmann</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Assessment of long-term cultivated human precision-cut lung slices as an <italic>ex vivo</italic> system for evaluation of chronic cytotoxicity and functionality</article-title>. <source>J. Occup. Med. Toxicol.</source> <volume>12</volume>, <fpage>13</fpage>. <pub-id pub-id-type="doi">10.1186/s12995-017-0158-5</pub-id>
<pub-id pub-id-type="pmid">28559920</pub-id>
</mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nishikawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tokito</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hirono</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Inamura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Scheidecker</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Accurate evaluation of hepatocyte metabolisms on a noble oxygen-permeable material with low sorption characteristics</article-title>. <source>Front. Toxicol.</source> <volume>4</volume>, <fpage>810478</fpage>. <pub-id pub-id-type="doi">10.3389/ftox.2022.810478</pub-id>
</mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohta</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sugimoto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Horikawa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Okui</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sakaki</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Profiling of metabolic dysregulation in ovarian cancer tissues and biofluids</article-title>. <source>Sci. Rep.</source> <volume>14</volume>, <fpage>21555</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-024-72938-3</pub-id>
</mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palmer</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>Kotsianti</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cadman</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Boyd</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gerald</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Haber</surname>
<given-names>D. A.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>WT1 regulates the expression of the major glomerular podocyte membrane protein Podocalyxin</article-title>. <source>Curr. Biol.</source> <volume>11</volume>, <fpage>1805</fpage>&#x2013;<lpage>1809</lpage>. <pub-id pub-id-type="doi">10.1016/S0960-9822(01)00560-7</pub-id>
<pub-id pub-id-type="pmid">11719225</pub-id>
</mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Preu&#xdf;</surname>
<given-names>E. B.</given-names>
</name>
<name>
<surname>Schubert</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Werlein</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Stark</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Braubach</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>H&#xf6;fer</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>The challenge of long-term cultivation of human precision-cut lung slices</article-title>. <source>Am J Pathol</source> <volume>192</volume>, <fpage>239</fpage>&#x2013;<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajpath.2021.10.020</pub-id>
</mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ricci</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Ronco</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>New insights in acute kidney failure in the critically ill</article-title>. <source>Swiss Med. Wkly.</source> <volume>142</volume>, <fpage>3334</fpage>. <pub-id pub-id-type="doi">10.4414/smw.2012.13662</pub-id>
<pub-id pub-id-type="pmid">22923149</pub-id>
</mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rico</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mukherjee</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Konieczkowski</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bruggeman</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>R. T.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>WT1-interacting protein and ZO-1 translocate into podocyte nuclei after puromycin aminonucleoside treatment</article-title>. <source>Am. J. Physiol. Ren. Physiol.</source> <volume>289</volume>, <fpage>F431</fpage>&#x2013;<lpage>F441</lpage>. <pub-id pub-id-type="doi">10.1152/ajprenal.00389.2004</pub-id>
<pub-id pub-id-type="pmid">15798086</pub-id>
</mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sauzay</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>White-Koning</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hennebelle</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Deluche</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Delmas</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Imbs</surname>
<given-names>D. C.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Inhibition of OCT2, MATE1 and MATE2-K as a possible mechanism of drug interaction between pazopanib and cisplatin</article-title>. <source>Pharmacol. Res.</source> <volume>110</volume>, <fpage>89</fpage>&#x2013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2016.05.012</pub-id>
<pub-id pub-id-type="pmid">27178732</pub-id>
</mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schl&#xfc;ter</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Margolis</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Apicobasal polarity in the kidney</article-title>. <source>Exp. Cell Res.</source> <volume>318</volume>, <fpage>1033</fpage>&#x2013;<lpage>1039</lpage>. <pub-id pub-id-type="doi">10.1016/j.yexcr.2012.02.028</pub-id>
<pub-id pub-id-type="pmid">22421511</pub-id>
</mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ying</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models</article-title>. <source>Sci. Rep.</source> <volume>6</volume>, <fpage>32087</fpage>. <pub-id pub-id-type="doi">10.1038/srep32087</pub-id>
<pub-id pub-id-type="pmid">27580845</pub-id>
</mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siwczak</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hiller</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pfannkuche</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>M. R.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Culture of vibrating microtome tissue slices as a 3D model in biomedical research</article-title>. <source>J. Biol. Eng.</source> <volume>17</volume>, <fpage>36</fpage>. <pub-id pub-id-type="doi">10.1186/s13036-023-00357-5</pub-id>
</mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takemura</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ishii</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ikeyama</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Esashika</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>New <italic>in vitro</italic> screening system to detect drug-induced liver injury using a culture plate with low drug sorption and high oxygen permeability</article-title>. <source>Drug Metab. Pharmacokinet.</source> <volume>52</volume>, <fpage>100511</fpage>. <pub-id pub-id-type="doi">10.1016/j.dmpk.2023.100511</pub-id>
</mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uwai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ida</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tsuji</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Katsura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Inui</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Renal transport of Adefovir, Cidofovir, and Tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2)</article-title>. <source>Pharm. Res.</source> <volume>24</volume>, <fpage>811</fpage>&#x2013;<lpage>815</lpage>. <pub-id pub-id-type="doi">10.1007/s11095-006-9196-x</pub-id>
<pub-id pub-id-type="pmid">17372702</pub-id>
</mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wagner</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>K.-D.</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Scholz</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Schedl</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>The Major podocyte protein Nephrin is transcriptionally activated by the wilms&#x2019; Tumor suppressor WT1</article-title>. <source>J. Am. Soc. Nephrol.</source> <volume>15</volume>, <fpage>3044</fpage>&#x2013;<lpage>3051</lpage>. <pub-id pub-id-type="doi">10.1097/01.ASN.0000146687.99058.25</pub-id>
<pub-id pub-id-type="pmid">15579507</pub-id>
</mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>NADPH oxidase-mediated upregulation of connexin43 contributes to podocyte injury</article-title>. <source>Free Radic. Biol. Med.</source> <volume>53</volume>, <fpage>1286</fpage>&#x2013;<lpage>1297</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2012.07.012</pub-id>
<pub-id pub-id-type="pmid">22824863</pub-id>
</mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yokoo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yonezawa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Masuda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fukatsu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Katsura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Inui</surname>
<given-names>K.-I.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity</article-title>. <source>Biochem. Pharmacol.</source> <volume>74</volume>, <fpage>477</fpage>&#x2013;<lpage>487</lpage>. <pub-id pub-id-type="doi">10.1016/j.bcp.2007.03.004</pub-id>
<pub-id pub-id-type="pmid">17582384</pub-id>
</mixed-citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="custom" custom-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3136064/overview">Yuan Pang</ext-link>, Tsinghua University, China</p>
</fn>
<fn fn-type="custom" custom-type="reviewed-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3169122/overview">Kyoung-Sik Moon</ext-link>, Korea Institute of Toxicology, Republic of Korea</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3454018/overview">Meng-Meng Liu</ext-link>, First Affiliated Hospital of Fujian Medical University, China</p>
</fn>
</fn-group>
</back>
</article>